Share
PDF
Other content recommended for you
- The ‘serious’ factor in germline modification
- ‘Serious’ factor—a relevant starting point for further debate: a response
- Ethics of modifying the mitochondrial genome
- Moral reasons to edit the human genome: picking up from the Nuffield report
- Reproductive and therapeutic cloning, germline therapy, and purchase of gametes and embryos: comments on Canadian legislation governing reproduction technologies
- Genetics insight into the amyotrophic lateral sclerosis/frontotemporal dementia spectrum
- Similar early clinical presentations in familial and non-familial frontotemporal dementia
- Genetic counselling in ALS: facts, uncertainties and clinical suggestions
- 2014 Nobel Prize in Physiology or Medicine
- Genetic architecture of sporadic frontotemporal dementia and overlap with Alzheimer's and Parkinson's diseases